Artelus AI 

Artelus leverages advanced AI technology to enhance the detection and diagnosis of retinal diseases. Our Fundus AI (DRISTi) can capture 4 levels of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME), 16 DR-related pathologies, and 20 other multi-pathologies, providing comprehensive diagnostic capabilities.

Additionally, our OCT AI accurately identifies 7 retinal diseases. Both systems are equipped with explainable AI,
which generates heatmaps to highlight regions of interest, ensuring transparency
and aiding healthcare professionals in making informed clinical decisions.